Monozygotic twins clinically discordant for scleroderma show concordance for fibroblast gene expression profiles

Arthritis and Rheumatism

Volumn 52, Issue 10, 2005, Pages 3305-3314

  Zhou, Xiaodong ^a   Tan, Filemon K ^a   Xiong, Momiao ^b   Arnett, Frank C ^a   Feghali Bostwick, Carol A ^c,d  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLUSTER ANALYSIS; COL1A2 GENE; CONTROLLED STUDY; CTGF GENE; DIZYGOTIC TWINS; DNA MICROARRAY; FEMALE; FIBROBLAST; GENE; GENE EXPRESSION REGULATION; GENETIC IDENTIFICATION; GENETIC PREDISPOSITION; HUMAN; MALE; MOLECULAR MODEL; MONOZYGOTIC TWINS; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCLERODERMA; SKIN FIBROBLAST; SPARC GENE; STATISTICAL SIGNIFICANCE; SYSTEMIC SCLEROSIS; TWIN DISCORDANCE;

ADULT; CELLS, CULTURED; FIBROBLASTS; GENE EXPRESSION PROFILING; HUMANS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SCLERODERMA, SYSTEMIC; TWINS, MONOZYGOTIC;

EID: 26844493324     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21355     Document Type: Article

References (35)

1. Arnett FC, Cho M, Chatterjee S, Aguilar MB, Reveille JD, Mayes MD. Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts. Arthritis Rheum 2001;44:1359-62.
2. Feghali-Bostwick C, Medsger TA Jr, Wright TM. Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheum 2003;48:1956-63.
3. Kuroda K, Shinkai H. Gene expression of types I and III collagen, decorin, matrix metalloproteinases and tissue inhibitors of metalloproteinases in skin fibroblasts from patients with systemic sclerosis. Arch Dermatol Res 1997;289:567-72.
4. Mattila L, Airola K, Ahonen M, Hietarinta M, Black C, Saarialho-Kere U, et al. Activation of tissue inhibitor of metalloproteinases-3 (TIMP-3) mRNA expression in scleroderma skin fibroblasts. J Invest Dermatol 1998;110:416-21.
5. Igarashi A, Nashiro K, Kikuchi K, Sato S, Ihn H, Grotendorst GR, et al. Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis. J Invest Dermatol 1995;105:280-4.
6. Zhou X, Tan FK, Reveille JD, Wallis D, Milewicz DM, Ahn C, et al. Association of novel polymorphisms with the expression of SPARC in normal fibroblasts and with susceptibility to scleroderma. Arthritis Rheum 2002;46:2990-9.
7. Feghali CA, Bost KL, Boulware DW, Levy LS. Mechanism of pathogenesis in scleroderma. I. Overproduction of interleukin 6 by fibroblasts cultured from affected skin sites of patients with scleroderma. J Rheumatol 1992;19:1207-11.
8. Denton CP, Abraham DJ. Transforming growth factor-β and connective tissue growth factor: key cytokines in scleroderma pathogenesis. Curr Opin Rheumatol 2001;13:505-11.
9. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
10. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
11. Feghali CA, Wright TM. Identification of multiple, differentially expressed messenger RNAs in dermal fibroblasts from patients with systemic sclerosis. Arthritis Rheum 1999;42:1451-7.
12. Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J, et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 2002;30:e15.
13. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001;98:5116-21.
14. Wright GW, Simon RM. A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 2003;19:2448-55.
15. Pounds S, Cheng C. Improving false discovery rate estimation. Bioinformatics 2004;20:1737-45.
16. Simon R, Lam A. BRB-array tools user guide, version 3.2. Biometric Research Branch, National Cancer Institute; 2004.
17. Zhou X, Tan FK, Xiong M, Milewicz DM, Feghali CA, Fritzler MJ, et al. Systemic sclerosis (scleroderma): specific autoantigen genes are selectively overexpressed in scleroderma fibroblasts. J Immunol 2001;167:7126-33.
18. McShane LM, Radmacher MD, Freidlin B, Yu R, Li MC, Simon R. Methods for assessing reproducibility of clustering patterns observed in analyses of microarray data. Bioinformatics 2002;18: 1462-9.
19. Johnson RW, Tew MB, Arnett FC. The genetics of systemic sclerosis. Curr Rheumatol Rep 2002;4:99-107.
20. Zhou X, Tan FK, Wang N, Xiong M, Maghidman S, Reveille JD, et al. Genome-wide association study for regions of systemic sclerosis susceptibility in a Choctaw Indian population with high disease prevalence. Arthritis Rheum 2003;9:2585-92.
21. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999;286:531-7.
22. Malmstrom J, Westergren-Thorsson G, Marko-Varga G. A proteomic approach to mimic fibrosis disease evolvement by an in vitro cell line. Electrophoresis 2001;22:1776-84.
23. Wheeler AP, Ridley AJ. Why three rho proteins? RhoA, rhoB, rhoC, and cell motility. Exp Cell Res 2004;301:43-9.
24. Vardouli L, Moustakas A, Stournaras C. LIM-kinase 2 and cofilin phosphorylation mediate actin cytoskeleton reorganization induced by transforming growth factor-β. J Biol Chem 2005;280: 11448-57.
25. Muller JM, Metzger E, Greschik H, Bosserhoff AK, Mercep L, Buettner R, et al. The transcriptional coactivator FHL2 transmits rho signals from the cell membrane into the nucleus. EMBO J 2002;21:736-48.
26. Labalette C, Renard CA, Neuveut C, Buendia MA, Wei Y. Interaction and functional cooperation between the LIM protein FHL2, CBP/p300, and β-catenin. Mol Cell Biol 2004;24:10689-702.
27. Amaar YG, Thompson GR, Linkhart TA, Chen ST, Baylink DJ, Mohan S. Insulin-like growth factor-binding protein 5 (IGFBP-5) interacts with a four and a half LIM protein 2 (FHL2). J Biol Chem 2002;277:12053-60.
28. Harrison CA, Wiater E, Gray PC, Greenwald J, Choe S, Vale W. Modulation of activin and BMP signaling. Mol Cell Endocrinol 2004;225:19-24.
29. Varga J. Scleroderma and Smads: dysfunctional Smad family dynamics culminating in fibrosis [review]. Arthritis Rheum 2002; 46:1703-13.
30. Killeen N. T-cell regulation: Thy-1-hiding in full view. Curr Biol 1997;7:R774-7.
31. Haeryfar SM, Al-Alwan MM, Mader JS, Rowden G, West KA, Hoskin DW. Thy-1 signaling in the context of costimulation provided by dendritic cells provides signal 1 for T cell proliferation and cytotoxic effector molecule expression, but fails to trigger delivery of the lethal hit. J Immunol 2003;171:69-77.
32. Derdak S, Penney DP, Keng P, Felch ME, Brown D, Phipps RP. Differential collagen and fibronectin production by Thy 1+ and Thy 1- lung fibroblast subpopulations. Am J Physiol 1992;263:L283-90.
33. Sempowski GD, Derdak S, Phipps RP. Interleukin-4 and interferon-γ discordantly regulate collagen biosynthesis by functionally distinct lung fibroblast subsets. J Cell Physiol 1996;167:290-6.
34. Koumas L, Smith TJ, Feldon S, Blumberg N, Phipps RP. Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes. Am J Pathol 2003;163:1291-300.
35. Penney DP, Keng PC, Derdak S, Phipps RP. Morphologic and functional characteristics of subpopulations of murine lung fibroblasts grown in vitro. Anat Rec 1992;232:432-43.